TLR4 and metabolic dysfunction-associated steatotic liver disease: The TLR4/MyD88 signaling pathway was demonstrated to be activated in the HBV-transgenic mice with NAFLD and HepG2.2.15 cells with SA-induced steatosis and contributed to inhibition of HBV replication (34).